Acute lung injury
|
WikiDoc Resources for Acute lung injury |
|
Articles |
|---|
|
Most recent articles on Acute lung injury Most cited articles on Acute lung injury |
|
Media |
|
Powerpoint slides on Acute lung injury |
|
Evidence Based Medicine |
|
Cochrane Collaboration on Acute lung injury |
|
Clinical Trials |
|
Ongoing Trials on Acute lung injury at Clinical Trials.gov Trial results on Acute lung injury Clinical Trials on Acute lung injury at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Acute lung injury NICE Guidance on Acute lung injury
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Acute lung injury Discussion groups on Acute lung injury Patient Handouts on Acute lung injury Directions to Hospitals Treating Acute lung injury Risk calculators and risk factors for Acute lung injury
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Acute lung injury |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Overview
Acute lung injury (ALI) is a diffuse heterogeneous lung injury characterized by hypoxemia, non cardiogenic pulmonary edema, low lung compliance and widespread capillary leakage. ALI is caused by any stimulus of local or systemic inflammation, principally sepsis.
Acute Lung Injury (ALI) & Acute Respiratory Distress Syndrome (ARDS) are defined as:
- Bilateral pulmonary infiltrates on chest x-ray
- Pulmonary Capillary Wedge Pressure <18mmHg
- PaO2/FiO2* <300 = ALI
- PaO2/FiO2 <200 = ARDS
Primary ALI is caused by a direct injury to the lung (e.g. pneumonia). Secondary ALI is caused by an indirect insult (e.g. pancreatitis). There are two stages – the acute phase characterized by disruption of the alveolar-capillary interface, leakage of protein rich fluid into the interstitium and alveolar space and extensive release of cytokines and migration of neutrophils. A later reparative phase is characterized by fibroproliferation, and organization of lung tissue.
The patient has low lung volumes, atelectasis, loss of compliance, ventilation-perfusion mismatch (increased deadspace) and right to left shunt.
Clinical features are - severe dyspnea, tachypnea and resistant hypoxemia. There are two diagnoses to be made: the syndrome of Acute Lung Injury and the underlying cause. ALI is a clinical diagnosis. There are probably two forms of ALI – primary ALI, caused by a direct injury to the lung, and secondary ALI, caused by an indirect injury to the lung. The cornerstone of treatment is to keep the PaO2 >60mmHg, without causing injury to the lungs with excessive O2 or volutrauma.
Pressure control ventilation is more versatile than volume control: but a volume limited strategy should be used. A number of adjunct therapies are available, none have proven effective. Of these, inhaled nitric oxide and prone positioning are most frequently used. Current ventilation strategies involve using low tidal volumes with or without high levels of PEEP. The open lung approach attempts to optimize lung mechanics and minimize phasic damage by strategically placing PEEP above Pflex. Ventilator induced lung injury is caused by volutrauma and excessive use of oxygen.
Steroids may have a role in chronic ARDS in patients, without infection, with high O2 requirements days to weeks into the disease process.
Pathology
The core pathology is disruption of the capillary-endothelial interface: this actually refers to two separate barriers – the endothelium and the basement membrane of the alveolus. In the acute phase of ALI, there is increased permeability of this barrier, and protein rich fluid leaks out of the capillaries. There are two types of alveolar epithelial cells – Type 1 pneumocytes represent 90% of the cell volume, and are easily damaged. Type 2 pneumocytes are more resistant to damage, which is important as these cells produce surfactant, transport ions and proliferate and differentiate into Type 1 cells.
The damage to the endothelium and the alveolar epithelium results in the creation of an open interface between the lung and the blood, facilitating the spread of micro-organisms from the lung systemically, stoking up a systemic inflammatory response. Moreover, the injury to epithelial cells handicaps the lung’s ability to pump fluid out of airspaces. Fluid filled airspaces, loss of surfactant, microvascular thrombosis and disorganized repair (which leads to fibrosis) reduces resting lung volumes (decreased compliance), increasing ventilation-perfusion mismatch, right to left shunt and the work of breathing. In addition, lymphatic drainage of lung units appears to be curtailed – stunned by the acute injury: this contributes to the build up of extravascular fluid.
Some patients rapidly recover from acute lung injury, and have no permanent sequelae. Prolonged inflammation and destruction of pneumocytes leads to fibroblastic proliferation, hyaline membrane formation and lung fibrosis. This fibrosing alveolitis may become apparent as early as five days after the initial injury. Subsequent recovery may be characterized by reduced physiologic reserve, and increased susceptibility to further lung injuries. Extensive microvascular thrombosis may lead to pulmonary hypertension, myocardial dysfunction and systemic hypotension.
Finally, it is essential to understand that although ALI is a diffuse process, it is also a heterogeneous process, and not all lung units are affected equally: normal and diseased tissue may exist side-by-side.
Acute Lung Injury Treatment
The cornerstone of treatment is to keep the PaO2 >60mmHg, without causing injury to the lungs with excessive O2 or volutrauma. Pressure control ventilation is more versatile than volume control, although breaths should be volume limited, to prevent stretch injury to the alveoli.
In general tidal volumes should not exceed 6ml/kg and plateau pressure should not exceed 30cmH2O. However tidal volumes of 4ml/kg should be delivered irrespective of airway pressure. The management of patients with respiratory failure goes beyond ventilation strategies, requiring a holistic multisystem approach. Providers are reminded of the ABCDEFG mnemonic.
A = Airway, establish a patient airway, intubate as necessary.
B = Breathing, commence mechanical ventilation and obtain an adequate minute volume to maintain oxygen delivery.
C = Circulation: blood pressure, pulse, intravascular volume – fluid resuscitation and vasopressors as necessary
D = Diagnosis, find the underlying problem and control the source.
E = Empiric therapy, for example antimicrobials for sepsis
FG = Feed the Gut, to prevent villus atrophy and bacterial translocation
The principles of mechanical ventilation are simple:
- Give enough oxygen to keep the PaO2 over 60mmHg preferably, and over 50mmHg at the very least.
- Avoid volutrauma and barotrauma, by keeping the tidal volumes in the 4-6ml/kg range and the airway plateau pressure below 30 - 35cmH2O (the tidal volume should not be less than 4ml/kg, irrespective of airway pressure).
The PaO2 is a function of the FiO2, the PEEP level, the mean airway pressure and the minute ventilation. The tidal volume, depending on what mode of ventilation is used, is determined by the pressure control level (in pressure controlled modes) or the tidal volume dialed up on the ventilator (in volume controlled modes).
There is no clear evidence that any particular mode or strategy improves outcome in ALI, except for controlling tidal volumes and airway pressures. What follows is a suggested starting strategy:
- Start with a high FiO2 (use the same FiO2 on the patient following intubation as before).
- Set the CPAP/PEEP level – if the patient has a P/F ratio of 200-300 start with CPAP/PEEP of 5cmH2O, if the P/F ratio is <200, use a CPAP/PEEP of 10cmH2O.
- For inspiratory support, use a decelerating flow pattern, with a tidal volume of 5-6ml/kg, of if pressure control is being used, a pressure limit which gives a tidal volume of 5-6ml/kg (1).
Please see tutorials on ventilator strategy.
It is important to note that ARDS is a disease of altered lung compliance. This is reduced due to the presence of large quantities of extravascular lung water. However, chest wall compliance may also be low - in patients who are edematous, have had massive fluid resuscitation or have abdominal hypertension. In this situation, the chamber in which the lungs are inflating (the chest), bears more resemblance to a brick wall than a rib cage with muscles. Higher inflation pressures are required to inflate the lungs in these circumstances and higher PEEP is required to maintain FRC.
The choice of mode of ventilation is institution specific. The majority of intensive care units in the United States continue to use volume controlled modes of ventilation to treat ARDS. Severe hypoxemia is managed by increasing mean airway pressure by escalating levels of PEEP and rapid respiratory rates. The logic behind increasing mean airway pressure is that much of the ventilation perfusion mismatch contributing to hypoxia occurs at end expiration (click here for more information). Although the majority cases can be managed in this way, more versatile modes are available, under the pressure control umbrella.
Pressure control modes have the advantage of allowing us manipulate the mean airway pressure by prolonging inspiration, and this may improve oxygenation without increasing peak or plateau pressures . In addition, pressure control may improve gas distribution at the end of inspiration, particularly where different lung units have different resistance patterns (ALI is, after all, a heterogeneous process).
The drawback of prolonging inspiration, and, in effect, inverting the I:E ratio (2;3), is that the patient may experience a lot of discomfort, and requires deep sedation. Further, incomplete expiration tends to reduce CO2 elimination, and the patient will develop “permissive hypercapnia” and respiratory acidosis. As we now know that ventilator induced lung injury causes much more trouble than respiratory acidosis, we do not consider the latter to be a major problem (4). Newer pressure control modes such as BiLevel / Airway Pressure Release ventilation have been developed to address the problem of patient discomfort in inverse ratio ventilation; with some success.
See also
http://www.ccmtutorials.com/rs/ali/index.htm Acute respiratory distress syndrome
References
Patrick Neligan MD (University of Pennsylvania)